title: Respiratory medication use in an Australian developmental disability clinic population: messages for health care professionals.
abstract: Australian data suggest up to 15% of people with intellectual disability (ID) have asthma. The inhaled route of administration is optimal for the management of obstructive airways diseases; however, correct inhaler use requires dexterity and particular breathing patterns and potentially represents a problem in this population due to physical and cognitive deficits. Understanding the nature and extent of inhaler use in persons with ID is important, as correct inhaler technique is imperative for optimal clinical outcomes; however, currently no evidence base exists to inform health professionals. This study describes respiratory medication use, reported prevalence of asthma, and asthma management practices undertaken in a clinic sample of Australian adults with ID. Results showed a prevalence of retrospectively reported asthma of 6%, with 86% of asthma patients prescribed inhaled medication. A review of patient records also indicated omission of some recommended asthma management strategies.
authors.affiliation: Woolcock Institute of Medical Research and Discipline of Pharmacology, Sydney Medical School, The University of Sydney, PO Box M77, Missenden Road, NSW 2050, Australia.
authors.forename: Sharon R
authors.initials: SR
authors.lastname: Davis
authors.affiliation: Centre for Disability Studies, Sydney Medical School, University of Sydney, Level 1, Medical Foundation Building - K25, 92-94 Parramatta Road, Camperdown, NSW 2050, Australia.
authors.forename: Seeta
authors.initials: S
authors.lastname: Durvasula
authors.affiliation: Synergy Medical Practice, PO Box 83, St Leonards, NSW 2065, Australia.
authors.forename: Diana
authors.initials: D
authors.lastname: Merhi
authors.affiliation: Woolcock Institute of Medical Research and Discipline of Pharmacology, Sydney Medical School, The University of Sydney, PO Box M77, Missenden Road, NSW 2050, Australia.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Young
authors.affiliation: Woolcock Institute of Medical Research and Discipline of Pharmacology, Sydney Medical School, The University of Sydney, PO Box M77, Missenden Road, NSW 2050, Australia.
authors.forename: Daniela
authors.initials: D
authors.lastname: Traini
authors.affiliation: Woolcock Institute of Medical Research and Discipline of Pharmacology, Sydney Medical School, The University of Sydney, PO Box M77, Missenden Road, NSW 2050, Australia.
authors.forename: Sinthia Z
authors.initials: SZ
authors.lastname: Bosnic-Anticevich
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000554:Ambulatory Care Facilities; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000150:complications* / Q000188:drug therapy*; D001315:Australia; D015897:Comorbidity; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006282:Health Personnel; D006801:Humans; D008607:Intellectual Disability / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009330:Nebulizers and Vaporizers; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D018927:Anti-Asthmatic Agents; D005938:Glucocorticoids